About Renovare Therapeutics
Renovare Therapeutics is a private company based in Boulder, Colorado, incorporated in 2026 in Delaware. It has reported $100,000 raised in one offering on Form D since October 2026. Its chief executive is Elizabeth Scott.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Oct 2, 2026 | $100,000of $1.0M target | 1 | $100K | OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Renovare Therapeutics's Form D filed Oct 2, 2026.
